Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Capturing Canadian Real-World Data for AML Chemotherapy Ineligible Patients on Venetoclax (LIVEN)

NCT05424562 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT05424562
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05424562 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Capturing Canadian Real-World Data for AML Chemotherapy Ineligible Patients on Venetoclax (LIVEN)
Lead sponsor
AbbVie
Phase
Observational
Overall status
Terminated
Start date
September 7, 2022
Completion date
August 31, 2026
Enrollment
210 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia